Publications
25
Citations
583
Est. group size
—
Recurring co-author estimate
Active years
24
Publishing since 2003
Daniel W. Woodall develops analytical chemistry methods for measuring and characterizing proteins, especially therapeutic antibodies used as drugs. His work combines separation techniques like liquid chromatography with mass spectrometry (which identifies molecules by their mass) to map protein sequences, assess modifications such as glycosylation, and study how antibodies bind their targets.
Publication output was highest around 2019-2020 and has been steady at roughly one to three papers per year since, with a recent uptick in 2026.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Utilization of Tandem-Column UHPLC for High-Throughput Peptide Mapping of Therapeutic Proteins
Analytical Chemistry · 2026
- Utilizationof Tandem-Column UHPLC for High-ThroughputPeptide Mapping of Therapeutic Proteins
Figshare · 2026
- Utilizationof Tandem-Column UHPLC for High-ThroughputPeptide Mapping of Therapeutic Proteins
Figshare · 2026
- Native SEC and Reversed-Phase LC–MS Reveal Impact of Fab Glycosylation of Anti-SARS-COV-2 Antibodies on Binding to the Receptor Binding Domain
Analytical Chemistry · 2023
- Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometry
mAbs · 2022
- Rapid high mass resolution mass spectrometry using matrix-assisted ionization
Methods · 2016
- Journal of the American Society for Mass Spectrometry×6
- Analytical Chemistry×6
- Journal of the American Chemical Society×3
- Figshare×2
- Chemical Communications×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile